skip to Main Content

Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons

The overarching goal of this study is to formulate evidence-based recommendations about the preferred CD4 T-cell count at which to initiate antiretroviral therapy (ART), and the preferred initial ART regimen, that would minimize cancer incidence among HIV-infected persons.

Investigator: Silverberg, Michael

Funder: National Cancer Institute

Explore all studies and publications

Back To Top